Cargando…
Hypokalemia with Trifluoperazine at Therapeutic Dose
This case report outlines a rare presentation of hypokalemia with therapeutic doses of trifluoperazine in a patient with schizophrenia. Although there was comorbid diabetes mellitus in the patient, its effect was ruled out subsequently. On recovery, rechallenge with trifluoperazine resulted in the s...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461850/ https://www.ncbi.nlm.nih.gov/pubmed/28615774 http://dx.doi.org/10.4103/0253-7176.207315 |
_version_ | 1783242414821998592 |
---|---|
author | Rehman, Sajjadur Chetia, Dhruba Jyoti |
author_facet | Rehman, Sajjadur Chetia, Dhruba Jyoti |
author_sort | Rehman, Sajjadur |
collection | PubMed |
description | This case report outlines a rare presentation of hypokalemia with therapeutic doses of trifluoperazine in a patient with schizophrenia. Although there was comorbid diabetes mellitus in the patient, its effect was ruled out subsequently. On recovery, rechallenge with trifluoperazine resulted in the same effect at a milder level. No cardiac abnormalities were detected with the presentation. Naranjo adverse drug reaction probability scale reported definite relation with the drug. |
format | Online Article Text |
id | pubmed-5461850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-54618502017-06-14 Hypokalemia with Trifluoperazine at Therapeutic Dose Rehman, Sajjadur Chetia, Dhruba Jyoti Indian J Psychol Med Case Report This case report outlines a rare presentation of hypokalemia with therapeutic doses of trifluoperazine in a patient with schizophrenia. Although there was comorbid diabetes mellitus in the patient, its effect was ruled out subsequently. On recovery, rechallenge with trifluoperazine resulted in the same effect at a milder level. No cardiac abnormalities were detected with the presentation. Naranjo adverse drug reaction probability scale reported definite relation with the drug. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5461850/ /pubmed/28615774 http://dx.doi.org/10.4103/0253-7176.207315 Text en Copyright: © 2017 Indian Psychiatric Society http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Rehman, Sajjadur Chetia, Dhruba Jyoti Hypokalemia with Trifluoperazine at Therapeutic Dose |
title | Hypokalemia with Trifluoperazine at Therapeutic Dose |
title_full | Hypokalemia with Trifluoperazine at Therapeutic Dose |
title_fullStr | Hypokalemia with Trifluoperazine at Therapeutic Dose |
title_full_unstemmed | Hypokalemia with Trifluoperazine at Therapeutic Dose |
title_short | Hypokalemia with Trifluoperazine at Therapeutic Dose |
title_sort | hypokalemia with trifluoperazine at therapeutic dose |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461850/ https://www.ncbi.nlm.nih.gov/pubmed/28615774 http://dx.doi.org/10.4103/0253-7176.207315 |
work_keys_str_mv | AT rehmansajjadur hypokalemiawithtrifluoperazineattherapeuticdose AT chetiadhrubajyoti hypokalemiawithtrifluoperazineattherapeuticdose |